Product Name: 2-[1-(Mercaptomethyl) cyclopropyl]acetic acid CAS NO:162515-68-6
Chemical & Physical Properties:
Appearance : Off-White Solid
Boiling Point:290.1℃at 760 mmHg
Montelukast sodium is an orally effective selective leukotriene receptor antagonist, which can specifically inhibit cysteyl leukotriene receptors. It was successfully developed by Merck, Germany. It was successfully developed in Canada, Finland, Listed in Mexico. It is suitable for the prevention and long-term treatment of asthma in adults and children, including the prevention of asthma symptoms during the day and night, the treatment of asthma patients who are sensitive to aspirin, and the prevention of bronchoconstriction caused by exercise. It can also be used to relieve other treatments for 15 years and older. Seasonal allergic rhinitis symptoms in patients who are ineffective or intolerant.
If you are interested in our products or have any questions, please feel free to contact us!
Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.